Dr Shivashni Deo

Postdoctoral Research Associate
Medicine, Westmead Clinical School

C24 - Westmead Hospital
The University of Sydney
NSW 2006 Australia

T: + 61 2 9845 9072
F: + 61 2 9845 9102
E:

On this page

Themes | Keywords | Publications

 

Keywords

Immunology

Publications

2013 | 2012 | 2011 | 2010 | 2009

2013

   
  • Blyth, E., Clancy, L., Simms, R., Ma, C., Burgess, J., Deo, S., Byth, K., Dubosq, M., Shaw, P., Micklethwaite, K., Gottlieb, D. (2013), Donor-derived CMV specific T-cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. Blood. 121(18), 3745-3758. [Abstract]

2012

   
  • Gaundar, S., Clancy, L., Blyth, E., Meyer, W., Gottlieb, D. (2012), Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus. Cytotherapy. 14(9), 1119-1130. [Abstract]
  • Blyth, E., Gaundar, S., Clancy, L., Simms, R., Bilmon, I., Micklethwaite, K., Gottlieb, D. (2012), Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients. Cytotherapy. 14(6), 724-732. [Abstract]
  • Gaundar, S., Blyth, E., Clancy, L., Simms, R., Ma, C., Gottlieb, D. (2012), In vitro generation of influenza-specific polyfunctional CD4(+) T cells suitable for adoptive immunotherapy. Cytotherapy. 14(2), 182-193. [Abstract]

2011

   
  • Blyth, E., Clancy, L., Simms, R., Gaundar, S., O╩╝connell, P., Micklethwaite, K., Gottlieb, D. (2011), BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses. Transplantation. 92(10), 1077-84. [Abstract]

2010

   
  • Gaundar, S., Bendall, L. (2010), The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies. Current drug targets. 11(7), 823-33. [Abstract]

2009

   
  • Gaundar, S., Bradstock, K., Bendall, L. (2009), p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells. Cell Cycle. 8(18), 2975-2983. [Abstract]